Recently, studies have introduced muscle-related biomarkers, including growth differentiation factor-15 (GDF-15), GDF-8 (myostatin), activin A, and follistatin that could be used as identifiable markers of sarcopenia [13,14,15], but a lack of studies may limit the confirmation of predictable biomarkers. This evidence concerns the gene MSTN and sarcopenia.